Fingerprint
Dive into the research topics of 'Lower Dose Infliximab for Ulcerative Colitis: How Low Can We Go and How Much Can be Saved?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Lower Dose Infliximab for Ulcerative Colitis: How Low Can We Go and How Much Can be Saved?
George P. Christophi, Matthew A. Ciorba
- Division of Gastroenterology
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences
- Siteman Cancer Center
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Center of Regenerative Medicine
- DBBS - Immunology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- DBBS - Cancer Biology
Research output: Contribution to journal › Editorial
1
Scopus
citations